PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-62

  1. 7,655 Posts.
    lightbulb Created with Sketch. 6934
    Dude you excellent suggestion got lost in the furore - I'd suggest starting a separate thread.

    Even if you fell short of the required 5%, the motion would garner enough attention via shareholder signalling, that management would be compelled to be more forthright on MPS data and often alluded to partnerships by management therein. The more transparency/clarity the better in the end ambitions of either an emerging partnership or failing that, the ousting of PR....
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.